Study guide
6.5 Pulmonary Toxicology, Carcinogenicity, and Reproductive Hazards
CIH Certified Industrial Hygienist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The CIH Exam and How to Use This Guide
1.1 CIH Exam Format, Scoring, and Test-Day Logistics 1.2 Eligibility, Application Windows, Fees, and Certification Maintenance 1.3 The BGC Blueprint, Subject Areas, and a Calculation-First Study Plan
2 Chapter 2: Basic Science & Calculations
2.1 Gas Laws and Vapor Calculations 2.2 Unit Conversions: ppm, mg/m³, and Standard Temperature/Pressure 2.3 Fluid Mechanics and Airflow Fundamentals
3 Chapter 3: Air Sampling & Instrumentation
3.1 Active and Passive Air Sampling Strategies 3.2 Particulate and Aerosol Sampling 3.3 Direct-Reading Instruments and Calibration
4 Chapter 4: Analytical Chemistry & Lab Methods
4.1 Gas Chromatography and Mass Spectrometry 4.2 High-Performance Liquid Chromatography and Ion Chromatography 4.3 Spectroscopy and Elemental Analysis 4.4 Gravimetric, Microscopy, and Wet Chemical Methods 4.5 Laboratory Quality Assurance, Chain of Custody, and Desorption Efficiency
5 Chapter 5: Biostatistics & Epidemiology
5.1 Lognormal Distributions and Exposure Data Statistics 5.2 Upper Confidence Limits (UCL95) and Compliance Decision Rules 5.3 Epidemiological Study Designs and Measures of Association 5.4 Sampling Strategy: Sample Size, Power, and Worker Selection
6 Chapter 6: Toxicology & Biological Monitoring
6.1 Dose-Response Relationships and Points of Departure 6.2 Toxicokinetics: Absorption, Distribution, Metabolism, and Elimination 6.3 Aerosol Deposition, Clearance, and Respiratory Tract Dosimetry 6.4 Hepatic, Renal, Neurologic, and Hematologic Target Organ Toxicity 6.5 Pulmonary Toxicology, Carcinogenicity, and Reproductive Hazards 6.6 OEL Frameworks, Classifications, and Excursion Limits 6.7 Chemical Mixtures and Extended Work-Shift OEL Adjustments 6.8 Biological Exposure Indices (BEIs) and Biomonitoring
7 Chapter 7: Biohazards & Indoor Environmental Quality
7.1 Mold, Fungi, and Microbial Contaminants 7.2 Infectious Agents, Bloodborne Pathogens, and Biosafety Levels 7.3 Indoor Environmental Quality (IEQ) Investigations 7.4 Sanitation, Potable Water, and Personal Hygiene Programs
8 Chapter 8: Community Exposure & Environmental Health
8.1 Clean Air Act Framework, NAAQS, and New Source Review 8.2 Hazardous Air Pollutants, CEMS, and EPA Reference Methods 8.3 Atmospheric Stability, Lapse Rates, and Plume Morphology 8.4 Gaussian Plume Modeling, Plume Rise, and Environmental Fate 8.5 HAZWOPER Scope, Mandates, and Training Tiers 8.6 Protection Levels, Site Zoning, Incident Command, and Decontamination 8.7 Water Pollution, Hazardous Waste, and Community Right-to-Know
9 Chapter 9: Health Risk Analysis & Hazard Communication
9.1 GHS Hazard Classification: Health and Physical Hazard Criteria 9.2 GHS Labels, Safety Data Sheets, and Trade Secret Rules 9.3 The AIHA Exposure Assessment Strategy and Similar Exposure Groups 9.4 Qualitative Exposure Profiling and the AIHA Risk Matrix 9.5 Quantitative Health Risk Characterization: HQ, HI, and ELCR 9.6 NIOSH Occupational Exposure Banding 9.7 Risk Communication and Reporting to Affected Parties
10 Chapter 10: Industrial Ventilation Principles & LEV Design
10.1 Elimination, Substitution, Isolation, Containment, and Process Change 10.2 LEV Hood Taxonomy and Capture Velocity Selection 10.3 Hood Airflow Equations, Entry Losses, and Hood Static Pressure 10.4 Particulate Transport Aerodynamics and Duct Sizing 10.5 Duct Friction, Fitting Losses, and System Balancing 10.6 Fan Categories and Pressure Dynamics Across the Fan 10.7 System Curves, the Fan Laws, and Density Corrections
11 Chapter 11: General Ventilation, Air Cleaning & Diagnostics
11.1 Dilution Ventilation Principles and Steady-State Modeling 11.2 Transient Purging and Air Distribution Geometry 11.3 Particulate Air Cleaning: Cyclones, Baghouses, Scrubbers, and ESPs 11.4 Gaseous Emission Control and Air Cleaner Selection 11.5 Ventilation System Troubleshooting and Testing
12 Chapter 12: Noise Measurement & Hearing Conservation
12.1 Acoustic Physics and Decibel Mathematics 12.2 Sound Propagation, Octave Bands, and Frequency Weighting 12.3 Noise Dose Metrics and OSHA versus ACGIH Criteria 12.4 Exchange Rates, Extended Shifts, and Dosimetry Field Protocols 12.5 Engineering Noise Controls and Hearing Protector Attenuation 12.6 Hearing Conservation Programs and Standard Threshold Shifts 12.7 Hand-Arm and Whole-Body Vibration
13 Chapter 13: Thermal Stress Assessment & Control
13.1 Wet Bulb Globe Temperature (WBGT) and Heat Stress Indices 13.2 Heat-Related Disorders, Acclimatization, and Work/Rest Regimens 13.3 Cold Stress Evaluation and Wind Chill
14 Chapter 14: Ionizing Radiation Protection
14.1 Ionizing Radiation Physics and Radioactive Decay Kinetics 14.2 Radiation Units, Radiobiology, and Health Effects 14.3 ALARA, Stay-Time, and the Inverse Square Law 14.4 Shielding Physics, Material Selection, and Gamma Constants 14.5 Radiation Detection Instruments and Spectrometry 14.6 Personnel Dosimetry, Dose Limits, and Contamination Surveys
15 Chapter 15: Non-Ionizing Radiation & Laser Safety
15.1 The Non-Ionizing Spectrum and Static/ELF Field Exposures 15.2 Radiofrequency and Microwave Exposure: SAR, Standards, and Surveys 15.3 Ultraviolet, Visible, and Infrared Radiation Hazards 15.4 Laser Safety Classifications and Optical Density Calculations 15.5 Illumination, Lighting Design, and Visual Performance
16 Chapter 16: Non-Engineering Controls & Personal Protective Equipment
16.1 Respiratory Protection Programs and Assigned Protection Factors 16.2 Maximum Use Concentration, Oxygen Deficiency, and Breathing Air 16.3 Particulate Filters, Sorbent Cartridges, and Change Schedules 16.4 Respirator Fit Testing Protocols 16.5 Chemical Protective Clothing and Dermal Exposure Control
17 Chapter 17: Ergonomics & Workstation Design
17.1 Soft-Tissue Biomechanics and WMSD Pathophysiology 17.2 Ergonomic Risk Factors and Their Interaction Effects 17.3 The Revised NIOSH Lifting Equation 17.4 RULA, REBA, the Strain Index, and the ACGIH HAL TLV 17.5 Anthropometry and Workstation Geometry 17.6 VDT Workstations, Hand Tool Design, and Administrative Ergonomics
18 Chapter 18: Work Environments & Industrial Processes
18.1 Welding Fume Emissions, Metal Fume Fever, and Cr(VI)/Manganese Toxicology 18.2 Foundry Operations and Hot Work Fire Prevention 18.3 Vapor Degreasing, Pickling, Electroplating, and Cyanide Baths 18.4 Spray Coatings, Isocyanates, and Semiconductor Manufacturing 18.5 Confined Spaces and High-Hazard Industrial Operations 18.6 Asbestos, Lead, and Silica: Regulated Substance Programs 18.7 Abrasive Blasting and Surface Preparation
19 Chapter 19: IH Program Management & Professional Ethics
19.1 The BGC Code of Ethics: Canons and Enforcement 19.2 Professional Liability, Standard of Care, and Expert Testimony 19.3 Occupational Health & Safety Management Systems (ISO 45001, ANSI Z10) 19.4 Exposure Records Access and Medical Surveillance 19.5 OSHA Injury and Illness Recordkeeping and Enforcement
6.5 Pulmonary Toxicology, Carcinogenicity, and Reproductive Hazards
Key Takeaways Explain This Topic AI
Pulmonary responses divide by solubility and mechanism: highly soluble irritants (ammonia, hydrogen chloride) attack the upper airway, while poorly soluble ones (phosgene, nitrogen dioxide, ozone) reach the alveoli and cause delayed pulmonary oedema.
Fibrogenic dusts (crystalline silica, asbestos, coal) produce irreversible pneumoconiosis; sensitisers (isocyanates, western red cedar, platinum salts) produce occupational asthma with no safe exposure once sensitised.
IARC groups (1, 2A, 2B, 3) classify hazard identification only and say nothing about potency or exposure; the ACGIH A1 to A5 and NTP known/reasonably anticipated categories use different criteria and different evidence thresholds.
Reproductive and developmental toxicants act at different windows: organogenesis in weeks 3 to 8 of gestation is the period of maximum structural teratogenic susceptibility.
Last updated: August 2026
Pulmonary Toxicology, Carcinogenicity, and Reproductive Hazards
The lung is both the principal route of entry and a target organ in its own right, and the two endpoints that dominate regulatory attention — cancer and reproductive harm — have their own classification systems that the exam expects you to distinguish.
1. Pulmonary Toxicology: Irritants, Fibrogenic Dusts, and Sensitizers +-------------------------------------------------------------+
- | RESPIRATORY TRACT TARGETING |
- +-------------------------------------------------------------+
- | |
- | UPPER AIRWAYS (Nasopharynx, Larynx) |
- | - High Water Solubility Gases: NH3, SO2, HCl, Formaldehyde |
- | - Acute rhinitis, laryngeal edema, reflex bronchospasm |
- | |
- | TRACHEOBRONCHIAL TREE |
- | - Moderate Water Solubility: Cl2, Methyl Bromide |
- | - Chemical bronchitis, wheezing, epithelial sloughing |
- | |
- | ALVEOLAR GAS-EXCHANGE BED |
- | - Low Water Solubility: Phosgene (COCl2), NO2, Ozone (O3) |
- | - Delayed non-cardiogenic pulmonary edema (6-24 hr latency)|
- | |
- | - Insoluble Fibrogenic Dusts: Silica, Asbestos, Coal |
- | - Pneumoconioses, Macrophage lysis, Interstitial Fibrosis |
- +-------------------------------------------------------------+
- Pulmonary Irritants by Water Solubility
Water Solubility Class Representative Chemicals Anatomical Site of Primary Impact Clinical Manifestations
High Solubility Ammonia (NH3), Sulfur Dioxide (SO2), Hydrogen Chloride (HCl) Upper respiratory tract (nose, pharynx, larynx) Immediate burning, lacrimation, severe pain, reflex laryngeal spasm; warning properties are immediate.
Moderate Solubility Chlorine (Cl2), Methyl Bromide Trachea, major bronchi, and bronchioles Severe coughing, chemical bronchitis, dyspnea, wheezing.
Low Solubility Phosgene (COCl2), Nitrogen Dioxide (NO2), Ozone (O3) Terminal bronchioles and alveolar gas-exchange spaces Minimal immediate pain or warning properties. Toxicant penetrates deep into alveoli, causing delayed endothelial-epithelial barrier destruction and fatal non-cardiogenic pulmonary edema after a 6 to 24-hour asymptomatic latency period .
Fibrogenic Dusts and Pneumoconioses
Crystalline Silica (α-Quartz, Cristobalite, Tridymite):
Inhaled respirable quartz particles (dae < 4 µm) reach alveoli and are engulfed by alveolar macrophages.
Surface silanol groups (-Si-OH) generate reactive oxygen species and destabilize phagolysosomal membranes, causing macrophage lysis and release of inflammatory cytokines ( IL-1β , TNF-α , TGF-β ).
Chronic cycle drives fibroblast proliferation and dense collagen deposition, forming whorled, hyalinized fibrotic nodules (silicotic nodules) predominantly in the upper lung zones, often with "eggshell" calcification of hilar lymph nodes .
Complications: Progressive Massive Fibrosis (PMF), marked predisposition to Tuberculosis (silicotuberculosis), and lung cancer (IARC Group 1).
Asbestos (Amphiboles: Crocidolite, Amosite; Serpentine: Chrysotile):
Straight, needle-like amphibole fibers (crocidolite, amosite) have high aspect ratios (> 3:1) and extreme biopersistence, penetrating deeply into peripheral pleura.
Induces Asbestosis (diffuse interstitial pulmonary fibrosis primarily in lower lung lobes), Pleural Plaques (parietal pleural collagen thickening), Bronchogenic Carcinoma (synergistic multiplicative interaction with tobacco smoking: non-smoker without asbestos = 1×; non-smoker with asbestos = 5×; smoker without asbestos = 10×; smoker with asbestos = 50--60× relative risk ), and Malignant Mesothelioma (pleural/peritoneal malignancy with 20-40 year latency, completely unlinked to smoking).
Beryllium (extBe):
Exposure in aerospace, electronics, and machining.
Induces Chronic Beryllium Disease (CBD) —a cell-mediated Type IV hypersensitivity granulomatous lung disease clinically identical to sarcoidosis.
Immunogenetic linkage: Strongly associated with specific HLA-DPB1 alleles having a glutamic acid at position 69 (E69).
Diagnostic standard: Beryllium Lymphocyte Proliferation Test (BeLPT) using peripheral blood or bronchoalveolar lavage fluid.
Occupational Asthma and Chemical Sensitization
Diisocyanates (Toluene Diisocyanate [TDI], Methylene Diphenyl Diisocyanate [MDI], Hexamethylene Diisocyanate [HDI]):
The leading cause of chemically induced occupational asthma.
Low-molecular-weight reactive electrophiles act as haptens , binding covalently to human serum albumin to form neoantigens.
Induce sensitization via combined Type I (IgE-mediated) and Type IV (T-cell mediated) mechanisms.
Once sensitized, subsequent exposure to sub-parts-per-billion (sub-ppb) concentrations can trigger life-threatening acute bronchoconstriction and status asthmaticus.
2. Carcinogenicity Classification Systems
Industrial hygienists must navigate and cross-correlate cancer evaluation systems from the International Agency for Research on Cancer ( IARC ) and the American Conference of Governmental Industrial Hygienists ( ACGIH ):
IARC Category IARC Definition ACGIH Category ACGIH Definition Representative Industrial Carcinogens
Group 1 Carcinogenic to humans (Sufficient human evidence) A1 Confirmed human carcinogen (Sufficient human epidemiological data) Asbestos, Benzene, Hexavalent Chromium [Cr(VI)], Crystalline Silica, Nickel compounds, Beryllium, Cadmium, Vinyl chloride, Arsenic, Formaldehyde
Group 2A Probably carcinogenic to humans (Limited human, sufficient animal) A2 Suspected human carcinogen (Human data limited, conflicting, or animal data highly suggestive) Trichloroethylene (TCE), 1,3-Butadiene, Ethylene Oxide, Dichloromethane (Methylene chloride), Acrylamide, Epichlorohydrin
Group 2B Possibly carcinogenic to humans (Limited animal, inadequate human) A3 Confirmed animal carcinogen with unknown relevance to humans Ethylbenzene, Carbon black, Titanium dioxide (respirable), Styrene, Chloroform, Cobalt metal
Group 3 Not classifiable as to carcinogenicity to humans A4 Not classifiable as a human carcinogen (Inadequate or conflicting data) Toluene, Xylene, Acetone, Isopropanol, Polyethylene
— (IARC Group 4 [probably not] discontinued) A5 Not suspected as a human carcinogen (Good evidence of non-carcinogenicity) Industrial substances tested rigorously with negative findings
3. Teratogenicity and Reproductive Toxicology
Workplace hazards can impair reproductive function in males and females or induce congenital malformations in the developing embryo/fetus during specific developmental windows ( organogenesis: gestational weeks 3 to 8 ).
Key Reproductive & Developmental Hazards
Inorganic Lead: Crosses the placenta freely, causing spontaneous abortion, premature birth, reduced birth weight, and permanent neurodevelopmental cognitive deficits in offspring; in males, induces oligospermia, decreased motility, and abnormal sperm morphology.
Ethylene Glycol Monomethyl Ether (2-Methoxyethanol / EGME) and Ethylene Glycol Monoethyl Ether (2-Ethoxyethanol / EGEE):
Metabolized by alcohol dehydrogenase to methoxyacetic acid (MAA) and ethoxyacetic acid (EAA) .
MAA and EAA inhibit histone deacetylases and disrupt cellular bioenergetics.
Induce severe testicular atrophy , germ cell apoptosis, oligospermia/azoospermia, and profound teratogenesis (neural tube defects, cardiovascular anomalies, skeletal resorptions).
Carbon Monoxide: Fetal hemoglobin (HbF) has a higher binding affinity for CO than maternal adult hemoglobin (HbA), and fetal elimination kinetics are substantially slower, causing disproportionately severe fetal hypoxia and stillbirth.
Ionizing Radiation: Teratogenic threshold effects: microcephaly, mental retardation, and severe organ malformations following exposure during organogenesis (threshold ≈ 0.05--0.10 Gy).
- 4. Worked Step-by-Step Practical Diagnostic & Scenario Examples
- Worked Example 5.2.1: Target Organ and Biochemical Mechanism Matching
Problem: A plant industrial hygienist conducts an exposure audit across four manufacturing units:
Unit A: Solvent degreasing with n-hexane.
Unit B: Polyvinyl chloride polymerization with vinyl chloride monomer.
Unit C: Electroplating with hexavalent chromium acid mists.
Unit D: Foam manufacturing with toluene diisocyanate (TDI).
Match each chemical agent to its specific target organ, active metabolite/intermediate, and clinical disease outcome.
Solution Analysis:
Unit Chemical Agent Primary Target Organ Critical Intermediate / Mechanism Definitive Clinical Outcome
A n-Hexane Peripheral Nervous System (Motor/Sensory Axons) 2,5-Hexanedione (2,5-HD) pyrrole adducts crosslink neurofilaments Distal sensorimotor polyneuropathy ("glove-and-stocking")
B Vinyl Chloride Hepatic Vasculature / Endothelium Chloroethylene oxide / chloroacetaldehyde DNA etheno-adducts Hepatic angiosarcoma
C Hexavalent Chromium [Cr(VI)] Respiratory Tract & Nasal Septum Intracellular reduction of Cr(VI) → Cr(III) generating reactive radicals and DNA crosslinks Nasal septum perforation, bronchogenic carcinoma
D Toluene Diisocyanate (TDI) Tracheobronchial Tree / Immune System Hapten conjugation with albumin producing Type I/IV sensitization Occupational asthma, sub-ppb severe bronchospasm
Worked Example 5.2.2: Multiplicative Synergistic Cancer Risk Calculation (Asbestos + Smoking)
Problem: Epidemiological data establish the following relative risk (RR) factors for bronchogenic lung cancer:
- Baseline unexposed non-smoker: RR = 1.0
- Non-smoker occupationally exposed to amphibole asbestos: RR = 5.0
- Heavy cigarette smoker without asbestos exposure: RR = 11.0
If the interaction between asbestos fibers and tobacco smoke carcinogens follows a classic multiplicative synergistic model :
Calculate the theoretical relative risk (RRcombined) for a heavily smoking asbestos insulation worker.
If the annual baseline lung cancer incidence in unexposed non-smokers is 12 per 100,000, calculate the projected annual incidence rate per 100,000 in this dual-exposure worker cohort.
Solution Steps:
Apply the Multiplicative Synergistic Model: R R combined = R R asbestos × R R smoking = 5.0 × 11.0 = 55.0 RR_{\text{combined}} = RR_{\text{asbestos}} \times RR_{\text{smoking}} = 5.0 \times 11.0 = 55.0 R R combined = R R asbestos × R R smoking = 5.0 × 11.0 = 55.0
Calculate absolute incidence rate: Incidence = Baseline Rate × R R combined = 12 × 55.0 = 660 cases per 100 , 000 workers/year \text{Incidence} = \text{Baseline Rate} \times RR_{\text{combined}} = 12 \times 55.0 = 660 \text{ cases per } 100,000 \text{ workers/year} Incidence = Baseline Rate × R R combined = 12 × 55.0 = 660 cases per 100 , 000 workers/year
Result: The combined relative risk is 55.0× baseline , illustrating how asbestos and cigarette smoke interact synergistically to drastically amplify pulmonary carcinogenic risk.